Article

Generating real-world tumor burden endpoints from electronic health record data: Comparison of RECIST, radiology-anchored, and clinician-anchored approaches for abstracting real-world progression in non-small cell lung cancer

2019-01-03

Abstract excerpt

Real-world evidence derived from electronic health records (EHRs) is increasingly recognized as a supplement to evidence generated from traditional clinical trials. In oncology, tumor-based Response Evaluation Criteria in Solid Tumors (RECIST) endpoints are collected in clinical trials. The best approach for collecting similar endpoints from EHRs remains unknown. We evaluated the feasibility of a traditional RECIS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7aa6a9dc-639e-5c4e-b28e-5c57c2406a89
DOI: 10.1101/504878

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Generating real-world tumor burden endpoints from electronic health record data: Comparison of RECIST, radiology-anchored, and clinician-anchored approaches for abstracting real-world progression in non-small cell lung cancerDOI 10.1101/504878Read

Validate Real-World Data-based Endpoint Measures of Cancer Treatment OutcomesSemantic proximity Read

BATPC: A biology-anchored tumor progression classification for interpreting multidimensional progression phenotypes across solid tumors.Semantic proximity Read

Real-World Data and Evidence in Lung Cancer: A Review of Recent DevelopmentsSemantic proximity Read

Validation and clinical discovery demonstration of a real-world data extraction platformSemantic proximity Read

Fully Automated Abstraction of Longitudinal Breast Oncology Records with Off-The-Shelf Large Language ModelsSemantic proximity Read

RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation.Semantic proximity Read

A Reproducible Health Informatics Pipeline for Simulating and Integrating Early-Phase Oncology Clinical, Biomarker, and Pharmacokinetic Data for Exploratory Decision-Support AnalyticsSemantic proximity Read

Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerSemantic proximity Read

Tumor marker-based RecistTM is superior to RECIST as criteria to predict the long-term benefits of targeted therapy in advanced non-small-cell lung cancer with driver gene mutations.Semantic proximity Read

AI-Augmented Clinical Decision Support in a Patient-Centric Precision Oncology RegistrySemantic proximity Read

Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non-Small Cell Lung or Colorectal Cancer.Semantic proximity Read

Approach to Machine Learning for Extraction of Real-World Data Variables from Electronic Health RecordsSemantic proximity Read